![]() |
|
|
Vol. 282, Issue 2, 873-881, 1997
- and Prostaglandin E-Induced Fevers in Rats: Possible
Involvement of Brain Angiotensin II Receptor in Fever
Induction1
The Department of Physiology, Yamaguchi University School of
Medicine, Ube Yamaguchi 755, Japan
We investigated the role of the brain angiotensin II (Ang II) receptor
subtypes AT1 and AT2 in the
development of fever induced in freely moving rats by administration of
interleukin-1
(IL-1
) or prostaglandin E2
(PGE2). Intraperitoneal (i.p.) injection of IL-1
(2 µg/kg) induced a marked fever of rapid onset.
Intracerebroventricular (i.c.v.) administration, immediately before
IL-1
injection, of a selective AT2 receptor
antagonist, CGP42112A (5 or 20 µg), reduced the fever in a
dose-related manner. Rats given an i.c.v. injection of
PGE2 (200 ng) developed a monophasic fever
response that was attenuated by i.c.v. treatment with CGP42112A (10 or
20 µg) in a dose-related manner. The IL-1
(2 µg/kg i.p.)- and
PGE2 (200 ng i.c.v.)-induced fevers were
unchanged by the selective AT1 receptor
antagonist losartan (60 µg i.c.v.). Treatment with exogenous Ang II
(100 ng i.c.v.), which itself had no effect on resting body
temperature, resulted in an enhancement of the
PGE2 (50 ng i.c.v.)-induced fever. The
administration of CGP42112A (2 and 5 µg) into the rostral
hypothalamus (preoptic/anterior hypothalamic region) reduced fevers
induced by IL-1
(2 µg/kg i.p.) or intrahypothalamic (i.h.)
PGE2 (100 ng). Moreover, i.h. injection of Ang II
(25 ng) augmented the PGE2 (25 ng i.h.)-induced
fever. Finally, the i.h. administration, 15 min before i.h.
PGE2 (100 ng), of the angiotensin-converting enzyme (ACE) inhibitor lisinopril (5 and 10 µg) attenuated the PGE2-induced fever. These results suggest that
brain AT2 receptors contribute to the induction
of such febrile responses in rats.
This article has been cited by other articles:
![]() |
Q. J. Pittman Endothelin-an emerging role in proinflammatory pathways in brain Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2006; 290(1): R162 - R163. [Full Text] [PDF] |
||||
![]() |
C. A. Dinarello Review: Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed Innate Immunity, August 1, 2004; 10(4): 201 - 222. [Abstract] [PDF] |
||||
![]() |
H. Shimizu, M. Miyoshi, K. Matsumoto, O. Goto, T. Imoto, and T. Watanabe The Effect of Central Injection of Angiotensin-Converting Enzyme Inhibitor and the Angiotensin Type 1 Receptor Antagonist on the Induction by Lipopolysaccharide of Fever and Brain Interleukin-1{beta} Response in Rats J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 865 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Romanovsky, N. Sugimoto, C. T. Simons, and W. S. Hunter The organum vasculosum laminae terminalis in immune-to-brain febrigenic signaling: a reappraisal of lesion experiments Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R420 - R428. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Steiner and L. G. S. Branco Central CO-heme oxygenase pathway raises body temperature by a prostaglandin-independent way J Appl Physiol, May 1, 2000; 88(5): 1607 - 1613. [Abstract] [Full Text] [PDF] |
||||